Arcellx, Inc. (ACLX)
NASDAQ: ACLX · IEX Real-Time Price · USD
30.00
+0.67 (2.28%)
At close:
Mar 27, 2023, 4:00 PM
30.60
+0.60 (2.00%)
After-hours:
Mar 27, 2023, 7:24 PM EDT
Arcellx Market Cap
Arcellx has a market cap or net worth of $1.42 billion as of March 28, 2023. Its market cap has increased by 339.29% in one year.
Market Cap
1.42B
Enterprise Value
1.14B
1-Year Change
339.29%
Ranking
Category
Stock Price
$30.00
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx, Inc.'s market cap has increased from $503.15M to $1.42B, an increase of 182.21%. That is a compound annual growth rate of 148.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2023 | 1.42B | 10.48% |
Mar 24, 2023 | 1.29B | 3.68% |
Mar 23, 2023 | 1.24B | -0.74% |
Mar 22, 2023 | 1.25B | -5.00% |
Mar 21, 2023 | 1.31B | 1.01% |
Mar 20, 2023 | 1.30B | -0.34% |
Mar 17, 2023 | 1.31B | 1.40% |
Mar 16, 2023 | 1.29B | 0.34% |
Mar 15, 2023 | 1.28B | -2.72% |
Mar 14, 2023 | 1.32B | 9.02% |
Mar 13, 2023 | 1.21B | 2.60% |
Mar 10, 2023 | 1.18B | -2.85% |
Mar 9, 2023 | 1.21B | -1.11% |
Mar 8, 2023 | 1.23B | 1.45% |
Mar 7, 2023 | 1.21B | -0.07% |
Mar 6, 2023 | 1.21B | -2.06% |
Mar 3, 2023 | 1.24B | 0.04% |
Mar 2, 2023 | 1.24B | 0.79% |
Mar 1, 2023 | 1.23B | -0.07% |
Feb 28, 2023 | 1.23B | -0.18% |
Feb 27, 2023 | 1.23B | 0.94% |
Feb 24, 2023 | 1.22B | 1.57% |
Feb 23, 2023 | 1.20B | -1.23% |
Feb 22, 2023 | 1.21B | 0.33% |
Feb 21, 2023 | 1.21B | -5.09% |
View and export this data all the way back to 2022.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tyra Biosciences, Inc. | 673.05M |
Belite Bio, Inc | 671.67M |
Arbutus Biopharma Corporation | 487.71M |
COMPASS Pathways plc | 431.06M |
Regencell Bioscience Holdings Limited | 335.60M |
Outlook Therapeutics, Inc. | 264.37M |
Kodiak Sciences Inc. | 251.61M |
Opthea Limited | 245.14M |
Esperion Therapeutics, Inc. | 122.52M |
Mind Medicine (MindMed) Inc. | 110.76M |